125 related articles for article (PubMed ID: 36641074)
21. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs.
Zhang Y; Chen W; Pan T; Wang H; Zhang Y; Li C
Biochem Biophys Res Commun; 2019 Apr; 511(3):566-572. PubMed ID: 30824187
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma.
Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370
[TBL] [Abstract][Full Text] [Related]
23. MiR-126 promotes esophageal squamous cell carcinoma via inhibition of apoptosis and autophagy.
Li M; Meng X; Li M
Aging (Albany NY); 2020 Jun; 12(12):12107-12118. PubMed ID: 32554852
[TBL] [Abstract][Full Text] [Related]
24. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
25. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
Wang Z; Zhang J; Li M; Kong L; Yu J
Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
27. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
Wang F; Wang J; Yang X; Chen D; Wang L
Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
[TBL] [Abstract][Full Text] [Related]
28. MYH9 promotes cell metastasis
Yang B; Liu H; Bi Y; Cheng C; Li G; Kong P; Zhang L; Shi R; Zhang Y; Zhang R; Cheng X
Int J Med Sci; 2020; 17(13):2013-2023. PubMed ID: 32788880
[TBL] [Abstract][Full Text] [Related]
29. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
31. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
Liu B; Li X; Li C; Xu R; Sun X
Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
[TBL] [Abstract][Full Text] [Related]
32. SNHG17, as an EMT-related lncRNA, promotes the expression of c-Myc by binding to c-Jun in esophageal squamous cell carcinoma.
Shen S; Liang J; Liang X; Wang G; Feng B; Guo W; Guo Y; Dong Z
Cancer Sci; 2022 Jan; 113(1):319-333. PubMed ID: 34714590
[TBL] [Abstract][Full Text] [Related]
33. The glioma-associated oncogene homolog 1 promotes epithelial--mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via Snail.
Min S; Xiaoyan X; Fanghui P; Yamei W; Xiaoli Y; Feng W
Cancer Gene Ther; 2013 Jul; 20(7):379-85. PubMed ID: 23788111
[TBL] [Abstract][Full Text] [Related]
34. High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients.
Jiang X; Zhou X; Yu X; Chen X; Hu X; Lu J; Zhao H; Cao Q; Gu Y; Yang Y; Jiang W; Jin M
Mod Pathol; 2022 Jul; 35(7):929-937. PubMed ID: 35194221
[TBL] [Abstract][Full Text] [Related]
35. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma.
Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M
J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361
[TBL] [Abstract][Full Text] [Related]
36. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
37. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
[TBL] [Abstract][Full Text] [Related]
38. USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1.
Song C; Peng J; Wei Y; Shao J; Chen X; Zhang X; Xu J
Exp Cell Res; 2021 Dec; 409(1):112884. PubMed ID: 34743935
[TBL] [Abstract][Full Text] [Related]
39. Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells.
Kubo Y; Tanaka K; Masuike Y; Takahashi T; Yamashita K; Makino T; Saito T; Yamamoto K; Tsujimoto T; Harino T; Kurokawa Y; Yamasaki M; Nakajima K; Eguchi H; Doki Y
J Transl Med; 2022 Aug; 20(1):383. PubMed ID: 36038893
[TBL] [Abstract][Full Text] [Related]
40. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]